SECURITIES AND EXCHANGE COMMISSION
                            WASHINGTON, D.C.  20549

                                  FORM 10-QSB


[x]  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
     ACT OF 1934.

     For the quarterly period ended March 31, 1998.

[ ]  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
     EXCHANGE ACT OF 1934.

     For the transition period from ___________________ to _______________

     Commission file number:  0-22421


                          MD HealthShares Corporation
        ---------------------------------------------------------------
       (Exact Name of Small Business Issuer as Specified in Its Charter)

            Louisiana                                  72-1301480
 ---------------------------------        --------------------------------
 (State or Other Jurisdiction of          (IRS Employer Identification No.)
   Incorporation or Organization)

             12021 Bricksome Avenue, Baton Rouge, Louisiana  70816
        ---------------------------------------------------------------
                   (Address of Principal Executive Offices)

                                (504) 293-3272
        ---------------------------------------------------------------
                (Issuer's Telephone Number, Including Area Code)

                                        
        ---------------------------------------------------------------
              (Former Name, Former Address and Former Fiscal Year,
                         if changed since Last Report)

Indicate by check mark whether the issuer:  (1) filed all reports required to be
filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the
past 12 months (or for such shorter period that the registrant was required to
file such reports), and (2) has been subject to such filing requirements for the
past 90 days.

Yes [ ]  No [X]

State the number of shares outstanding of each of the issuer's common equity, as
of the latest practicable date:

As of March 31, 1998, 1,076,200 shares of the Registrant's Class A Non-Voting
Common Stock and 1 share of the Registrant's Class B Common Stock were
outstanding.

Transitional Small Business Disclosure Format (check one)   Yes [X]  No [ ]

 
                                     PART I
                             FINANCIAL INFORMATION


Item 1.  Financial Statements.

 
 
 
CONSOLIDATED BALANCE SHEETS
MARCH 31, 1998 AND DECEMBER 31, 1997 - UNAUDITED
- --------------------------------------------------------------------------------------------------------------------------


                                                                                          MARCH 31,        DECEMBER 31,
ASSETS                                                                                      1998               1997    
                                                                                                     
CURRENT ASSETS:
 Cash and cash equivalents                                                               $ 1,024,119       $ 1,408,901     
 Investments                                                                               5,098,845         4,840,825        
 Interest receivable                                                                          78,864            55,095  
 Premiums receivable                                                                           6,091            24,554         
 Prepaid expenses                                                                             58,631            95,518  
                                                                                          ----------        ----------      
        Total current assets                                                               6,266,550         6,424,893     

RESTRICTED INVESTMENTS                                                                     1,000,000         1,000,000        

EQUIPMENT, net of accumulated depreciation of $38,844 in 1998
 and $30,429, in 1997                                                                         74,495            75,971  

OTHER                                                                                         35,070            35,378  
                                                                                          ----------        ----------      
TOTAL                                                                                    $ 7,376,115       $ 7,536,242 
                                                                                          ==========        ==========      

LIABILITIES AND STOCKHOLDERS' EQUITY

CURRENT LIABILITIES:
 Accounts payable and accrued expenses                                                   $   115,609       $   122,268     
 Claims payable and reserves for incurred but unreported claims                              517,882           145,131   
 Deferred revenue                                                                             22,782             2,385         
                                                                                          ----------        ----------      
        Total current liabilities                                                            656,273           269,784    
                                                                                          ----------        ----------      
CONTINGENCIES (Note 2)                                                                           --                --

STOCKHOLDERS' EQUITY (Note 3):
 Junior preferred voting stock, $1.00 par value, liquidation
  value $1,000, 7,500 shares authorized, 2,155 shares
  issued and outstanding in 1998; 2,152 in 1997                                                2,155             2,152
 Preferred stock, $1.00 par value, 2,000,000 shares authorized,
  none issued and outstanding in 1998 and 1997                                                    --                --     
 Common stock:
  Class A non-voting, $0.10 par value, 8,000,000 shares 
   authorized, 1,076,200 shares issued and outstanding
   in 1998; 1,075,000 in 1997                                                                107,620           107,500 
  Class B, $0.10 par value, 1 share authorized and
   outstanding in 1998 and 1997                                                                   --                --
 Additional paid-in capital                                                               11,751,400        11,732,023
 Accumulated deficit                                                                      (5,230,647)       (4,590,455)
 Treasury stock, at cost, 1,503 shares in 1998 and 1997                                       (8,000)           (8,000)    
 Unrealized gain on available-for-sale securities                                             97,314            23,238   
                                                                                          ----------        ----------      
        Total stockholders' equity                                                         6,719,842         7,266,458   
                                                                                          ----------        ----------      
TOTAL                                                                                    $ 7,376,115       $ 7,536,242
                                                                                          ==========        ==========      

 
See notes to consolidated financial statements.



 
CONSOLIDATED STATEMENTS OF OPERATIONS
THREE MONTH PERIODS ENDED MARCH 31, 1998 AND 1997 - UNAUDITED
- --------------------------------------------------------------------------------


                                                       THREE MONTHS ENDED
                                                             MARCH 31,
                                                    -------------------------
                                                       1998            1997
                                
REVENUES:
 Premiums                                            $ 686,175     $    1,310
 Investment income                                      83,274        124,592 
                                                     ---------      ---------  
        Total revenues                                 769,449        125,902
                                                     ---------      ---------  
EXPENSES:
 Medical expenses                                      583,249          1,126  
 Selling, general and administrative                   817,977        881,698 
 Depreciation                                            8,415          2,330
                                                     ---------      ---------  
        Total expenses                               1,409,641        885,154
                                                     ---------      ---------  
NET LOSS                                            $ (640,192)    $ (759,252)
                                                     =========      =========   

NET LOSS PER COMMON SHARE                           $    (0.60)    $    (0.71)
                                                     =========      =========   
AVERAGE OUTSTANDING COMMON SHARES                    1,075,400      1,071,001   
                                                     =========      =========   


See notes to consolidated financial statements.

 
MD HEALTHSHARES CORPORATION

CONSOLIDATED STATEMENTS OF CASH FLOWS
THREE MONTH PERIODS ENDED MARCH 31, 1998 AND 1997 - UNAUDITED
- --------------------------------------------------------------------------------
 
 
                                                                           1998            1997
                                                                                  
CASH FLOWS FROM OPERATING ACTIVITIES:
 Net loss                                                               $ (640,192)     $ (759,252)
 Adjustments to reconcile net loss to cash flows from
  operating activities:
   Depreciation                                                              8,415           2,330
   Changes in operating assets and liabilities:
    Premiums receivable                                                     18,463          (1,310)
    Interest receivable                                                    (23,769)         (2,014)
    Prepaid expenses                                                        36,887         (50,934)
    Accounts payable and accrued expenses                                   (6,659)         21,584
    Claims payable and reserves for incurred but unreported claims         372,751           1,127
    Deferred revenue                                                        20,397             -
                                                                        ----------      ----------
     Net cash used in operating activities                                (213,707)       (788,469)
                                                                        ----------      ----------
CASH FLOWS FROM INVESTING ACTIVITIES:
 Purchases of available-for-sale securities                               (999,069)            -
 Sales and maturities of available-for-sale securities                     815,125             -
 Other                                                                         308         (37,129)
 Purchase of equipment                                                      (6,939)        (15,656)
                                                                        ----------      ----------
     Net cash in investing activities                                     (190,575)        (52,785)
                                                                        ----------      ----------
CASH FLOWS FROM FINANCING ACTIVITIES:
 Proceeds from issuance of common stock                                     19,500             -
                                                                        ----------      ----------
NET DECREASE IN CASH                                                      (384,782)       (841,254)

CASH AND CASH EQUIVALANTS, Beginning of period                           1,408,901       9,147,525
                                                                        ----------      ----------
CASH AND CASH EQUIVELANTS, End of period                                $1,024,119      $8,306,271
                                                                        ==========      ==========
NON-CASH INVESTING AND FINANCING TRANSACTIONS:
 Unrealized gain on available-for-sale securities                       $   74,076      $     -
                                                                        ==========      ==========

 
See notes to consolidated financial statements.


 
MD HEALTHSHARES CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - UNAUDITED
- -------------------------------------------------------------------------------

1. BASIS OF PRESENTATION

   The accompanying unaudited consolidated financial statements have been
   prepared in accordance with generally accepted accounting principles for
   interim financial information and with the instructions to Form 10-QSB and
   Rule 310(g) of Regulation S-B.  Accordingly, they do not include all of the
   information and footnotes required by generally accepted accounting
   principles for complete financial statements.  In the opinion of management,
   all adjustments (consisting of normal recurring accruals) considered
   necessary for fair presentation have been included.  Operating results for
   the three month period ended March 31, 1998 are not necessarily indicative of
   the results that may be expected for the year ending December 31, 1998.

   RESERVES FOR INCURRED BUT UNREPORTED CLAIMS - The Company provides reserves
   for estimated incurred but unreported physician, hospital, and pharmacy
   services rendered to enrolled members during the period.  These reserves are
   presently based on the use of estimated medical cost ratios.  Changes in
   these estimates could be significant.

   REVENUE RECOGNITION - Premium revenues are recognized in the period in which
   the members are entitled to health care services.  Premiums collected in
   advance are deferred, (consistent with industry practice, third-party selling
   expenses are reported as a reduction of premium revenue.)

   REINSURANCE - The Company is covered under a medical reinsurance agreement
   that generally provides coverage for 80% of hospital services in excess of
   $50,000 per member per year, up to a yearly maximum of $1,000,000 per member.
   There were no reinsurance recoveries in 1998 and 1997.

   RISKS AND UNCERTAINTIES -  The Company's business could be impacted by
   continuing price pressure on new and renewal business, the Company's ability
   to effectively control health care costs, additional competitors entering the
   Company's markets, federal and state legislation in the area of health care
   reform, and governmental licensing regulations of HMOs and insurance
   companies.  Changes in these areas could adversely impact the Company's
   operations in the future.

   FINANCIAL PRESENTATION - Certain reclassifications have been made to prior
   period amounts to conform with current period presentation.

   For a summary of other significant accounting policies, refer to Note 1 of
   Notes to Consolidated Financial Statements included in the Company's annual
   report on Form 10KSB for the year ended December 31, 1997.



 
2. RECAPITALIZATION

   On March 22, 1997, the Company's stockholders approved a plan of
   recapitalization and amendments to the Company's articles of incorporation.
   In connection therewith, 7,500 shares of Junior Preferred Voting Stock,
   2,000,000 shares of Preferred Stock and 8,000,000 shares of Class A Non-
   Voting Stock were authorized.  Additionally, all of the Company's 2,142
   outstanding shares of Class A Common Stock were cancelled, and each former
   share of Class A Common Stock was converted into one share of Junior
   Preferred Voting Stock and 500 shares of Class A Non-Voting Common Stock.
   The average number of outstanding common shares have been restated to reflect
   the recapitalization.

3. COMMITMENTS AND CONTINGENCIES

   RESTRICTED INVESTMENTS - In connection with the filing for a COA, and as an
   ongoing requirement of the State of Louisiana, PCI has deposited with the
   Commissioner a safe keeping receipt of $1,000,000, consisting of certificates
   of deposits in ten separate banking corporations doing banking business
   within the State of Louisiana.

   REGULATORY REQUIREMENTS - The State of Louisiana has implemented financial
   regulations for HMOs requiring, among other things, minimum net worth
   requirements.  As of December 31, 1997, admitted assets, as defined, less
   liabilities, must be at least equal to $1,500,000 as reported in the
   statutory filing of such calendar year.  PCI was in compliance with the state
   statutory net worth requirement at December 31, 1997 and March 31, 1998.  The
   minimum state statutory net worth requirement will increase to $2.0 million
   on July 1, 1998.

4. STOCKHOLDERS' EQUITY

   During the first quarter, the Company sold three units of capital stock which
   were comprised of three shares of Junior Preferred Voting Stock and 1,200
   shares of Class A Non-Voting Common Stock.  The average number of outstanding
   common shares for the quarter reflects these transactions.


 
ITEM 2.  MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN OF OPERATION

   In February 1998, the Board of Directors appointed Patrick C. Powers as the
   first Chief Executive Officer for the Corporation and its subsidiary licensed
   health maintenance organization, Patient's Choice, Inc.  Mr. Powers has
   extensive experience in managed care, having previously served as the initial
   President and CEO of Gulf South Health Plans of Louisiana. Additional
   professional staff were added in certain key positions, including a new Chief
   Financial Officer with significant experience in developing startup managed
   care companies.

   Network development is the ongoing priority of the Company. Additional
   hospitals, physicians and physician groups, and ancillary service providers
   have been contracted as providers to better serve the clients of Patient's
   Choice and to create a marketable network of providers. The Medical Affairs
   Department established a Medical Executive Committee with statewide physician
   representation to assist physicians in providing high quality, cost-effective
   care. Specialty advisory workgroups have been established for the major
   medical specialties to allow physicians input into the development of
   practice guidelines.

   A sales and marketing staff is now in force with the objectives of working
   with selected brokers and conducting direct sales. As the Company's
   infrastructure, network, and medical management efforts are further
   developed, the sales team will focus increasingly on enrolling larger
   employer groups. As of August 1, 1998, the Company's subsidiary, Patient's
   Choice, had contracted with 132 clients to provide health care coverage for
   1,346 subscribers and 2,576 covered lives in its HMO and point of service
   plans.

   The Company incurred during the first quarter of 1998 and has incurred since
   the inception of operations in the first quarter of 1997 substantial losses
   from operations due to the lack of premium income resulting from delays in
   marketing its managed care health plans.  Such delays have been caused by
   difficulties the Company has encountered in securing provider contracts with
   hospitals and other ancillary medical providers in certain marketing areas of
   Louisiana, difficulties in hiring and retaining experienced full-time
   executive officers and the Company's late entry into the market for calendar
   year 1997 contracts. The Company anticipates that such losses will continue
   and accelerate as the number of enrollees in the Company's HMO subsidiary
   increases due to current marketing efforts until and unless the Company
   attains a sufficient number of enrollees that premium income will exceed
   operating expenses and claims payments. However, there can be no assurance
   that the Company has sufficient capital to fund such anticipated losses or
   that it will ever achieve sufficient numbers of enrollees to support
   profitable operations. The Company does not anticipate that it will require
   additional capital during the next twelve months.

   Certain statements, other than statements of historical fact, contained in
   this Quarterly Report on Form 10-QSB are forward-looking statements as
   defined in Section 21(E) of the Securities Exchange Act of 1934, as amended.
   These forward-looking statements are generally accompanied by such terms and
   phrases as , "anticipates", "estimates", "expects", "believes", "should",
   "projects", "scheduled", or similar statements. Although the Company believes
   that the expectations reflected in such forward-looking statements are
   reasonable, it can give no assurance that such expectations will prove to
   have been correct. All forward-looking statements in this Form 10-QSB are
   expressly qualified in their entirety by the cautionary statements in the
   paragraph.

   The Company has reviewed its year 2000 compliance status and has determined
   that all systems are sufficient except for one software package that will be
   replaced effective January 1, 1999.  The cost of this replacement will be
   minimal.



 
                                    PART II
                               OTHER INFORMATION

ITEM 2.  CHANGES IN SECURITIES AND USE OF PROCEEDS.

   During the first quarter of 1998 the Company sold three Units of its capital
stock, each Unit consisting of one share of Junior Preferred Voting Stock and
500 shares of Class A Non-Voting Common Stock, at a price of $6,500 per Unit,
for total sales proceeds of $19,500.  No underwriting discounts or commissions
were paid in connection with the sales.  The offer and sale of the Units were
exempt from registration under the Securities Act of 1933, as amended ("Act"),
by virtue of Section 3(11) of the Act and Rule 147 of the Commission promulgated
thereunder.  All offers and sales were made while the Units were subject to an
effective registration statement filed with the Louisiana Commissioner of
Securities.


ITEM 6.  EXHIBITS AND REPORTS ON FORM 8-K.

   (a) Exhibits.  The Company files the following exhibits:

   6(l)  Letter employment contract dated March 13, 1998 by and between MD
HealthShares Corporation and Adam Short.

   (b) Reports of Form 8-K. No reports on Form 8-K were filed during the three
months ended March 31, 1998.


                                   SIGNATURES

In accordance with the requirements of the Exchange Act, the registrant caused
this report to be signed on its behalf by the undersigned, thereunto duly
authorized.


                              MD HEALTHSHARES CORPORATION

Date:  August 17, 1998        /s/ Patrick C. Powers
                                 -----------------------------
                                 Patrick C. Powers
                                 Chief Executive Officer

Date:  August 17, 1998        /s/  Adam Short
                                 -----------------------------
                                 Adam Short
                                 Chief Financial Officer



 
                                 EXHIBIT INDEX


Exhibit 6(l)    Letter employment contract dated March 13, 1998 by and between
                MD HealthShares Corporation and Adam Short.